This list is an analysis based on recent market events. It's not an investment recommendation.
About
Sunhawk Vision Biotech, Inc., a drug development company, engages in the research and development of children's myopia eye drops, dry eye drops, and other nucleic acid new drugs for the treatment of ocular surface diseases in Taiwan. The company develops SHJ002 eye drops, which have completed a Phase 2 clinical trial for the treatment of dry eye disease in adult patients and corneal erosion in patients with Sjogren's syndrome, as well as in a Phase 2 clinical trial for myopia control in young children. Sunhawk Vision Biotech, Inc. was founded in 2019 and is based in Taipei, Taiwan.
What is Sunhawk Vision Biotech stock price today?▼
The current price of 7759.TWO is TWD52.70 TWD — it has decreased by -6.06% in the past 24 hours. Watch Sunhawk Vision Biotech stock price performance more closely on the chart.
What is Sunhawk Vision Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Sunhawk Vision Biotech stocks are traded under the ticker 7759.TWO.
Is Sunhawk Vision Biotech stock price growing?▼
7759.TWO stock has fallen by -5.72% compared to the previous week, the month change is a +23.85% rise, over the last year Sunhawk Vision Biotech has showed a -22.04% decrease.
What is Sunhawk Vision Biotech market cap?▼
Today Sunhawk Vision Biotech has the market capitalization of 3.69B
What is Sunhawk Vision Biotech revenue for the last year?▼
Sunhawk Vision Biotech revenue for the last year amounts to 0 TWD.
What is Sunhawk Vision Biotech net income for the last year?▼
7759.TWO net income for the last year is -172.39M TWD.
In which sector is Sunhawk Vision Biotech located?▼
Sunhawk Vision Biotech operates in the Other sector.
When did Sunhawk Vision Biotech complete a stock split?▼
Sunhawk Vision Biotech has not had any recent stock splits.
Where is Sunhawk Vision Biotech headquartered?▼
Sunhawk Vision Biotech is headquartered in Taipei, Taiwan.